This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nicklin, S. A. Articles by Baker, A. H. Search for Related Content PubMed PubMed Citation Articles by Nicklin, S. A. Articles by Baker, A. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Gene therapy Endothelium/vascular type/nitric oxide

(Circulation. 2000;102:231.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Selective Targeting of Gene Transfer to Vascular Endothelial Cells by Use of Peptides Isolated by Phage Display

Stuart A. Nicklin, PhD; Steve J. White, PhD; Sarah J. Watkins, PhD; Robert E. Hawkins, MD; Andrew H. Baker, PhD

From the Bristol Heart Institute, University of Bristol (S.A.N., S.J.W., A.H.B.), and the Paterson Institute for Cancer Research, University of Manchester (S.J.W., R.E.H.), UK. Drs Nicklin and Baker are now at the Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, UK. The first 2 authors contributed equally to this article.

Correspondence to Dr Andrew H. Baker, Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, Glasgow G11 6NT, UK. E-mail ab11f{at}clinmed.gla.ac.uk

Background—Gene transfer to vascular cells is a highly inefficient and nonselective process, defined by the lack of specific cell-surface receptors for both nonviral and viral gene delivery vectors.

Methods and Results—We used filamentous phage display to isolate a panel of peptides that have the ability to bind selectively and efficiently to quiescent human umbilical vein endothelial cells (HUVECs) with reduced or negligible binding to nonendothelial cells, including vascular smooth muscle cells and hepatocytes. By direct biopanning on HUVECs and a second approach involving preclearing steps before panning on HUVECs, we isolated and sequenced 140 individual phages and identified 59 peptides. We selected 7 candidates for further investigation by secondary screening of homogeneous phages on a panel of cell types. Using adenovirus-mediated gene transfer as a model gene delivery system, we cloned the peptide SIGYPLP and the positive control peptide KKKKKKK upstream of the S11e single-chain Fv ("adenobody") directed against the knob domain of the adenovirus to create fusion proteins. Adenovirus-mediated gene transfer via fiber-dependent infection was blocked with S11e, whereas inclusion of the KKKKKKK peptide retargeted gene transfer. The peptide SIGYPLP, however, retargeted gene delivery specifically to endothelial cells with a significantly enhanced efficiency over nontargeted adenovirus and without transduction of nontarget cells.

Conclusions—Our study demonstrates the feasibility of using small, novel peptides isolated via phage display to target gene delivery specifically and efficiently to HUVECs and highlights their use for retargeting both viral and nonviral gene transfer to vascular endothelial cells for future clinical applications.

Key Words: bacteriophages • peptides • gene therapy • viruses • cells

This article has been cited by other articles:

				D. Ghosh and M. A. Barry Selection of Muscle-Binding Peptides from Context-Specific Peptide-Presenting Phage Libraries for Adenoviral Vector Targeting J. Virol., November 1, 2005; 79(21): 13667 - 13672. [Abstract] [Full Text] [PDF]

				A. H. Baker, A. Kritz, L. M. Work, and S. A. Nicklin Cell-selective viral gene delivery vectors for the vasculature Exp Physiol, January 1, 2005; 90(1): 27 - 31. [Abstract] [Full Text] [PDF]

				K. EDA, S. EDA, and I. W. SHERMAN IDENTIFICATION OF PEPTIDES TARGETING THE SURFACE OF PLASMODIUM FALCIPARUM-INFECTED ERYTHROCYTES USING A PHAGE DISPLAY PEPTIDE LIBRARY Am J Trop Med Hyg, August 1, 2004; 71(2): 190 - 195. [Abstract] [Full Text] [PDF]

				P. Holig, M. Bach, T. Volkel, T. Nahde, S. Hoffmann, R. Muller, and R. E. Kontermann Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells Protein Eng. Des. Sel., May 1, 2004; 17(5): 433 - 441. [Abstract] [Full Text] [PDF]

				S. J. White, S. A. Nicklin, H. Buning, M. J. Brosnan, K. Leike, E. D. Papadakis, M. Hallek, and A. H. Baker Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors Circulation, February 3, 2004; 109(4): 513 - 519. [Abstract] [Full Text] [PDF]

				B. D MacNeill, I. Pomerantseva, H. C Lowe, S. N Oesterle, and J. P Vacanti Toward a new blood vessel Vascular Medicine, August 1, 2002; 7(3): 241 - 246. [Abstract] [PDF]

				S. A. Nicklin, P. N. Reynolds, M. J. Brosnan, S. J. White, D. T. Curiel, A. F. Dominiczak, and A. H. Baker Analysis of Cell-Specific Promoters for Viral Gene Therapy Targeted at the Vascular Endothelium Hypertension, July 1, 2001; 38(1): 65 - 70. [Abstract] [Full Text] [PDF]

				S. J. White, S. A. Nicklin, T. Sawamura, and A. H. Baker Identification of Peptides That Target the Endothelial Cell-Specific LOX-1 Receptor Hypertension, February 1, 2001; 37(2): 449 - 455. [Abstract] [Full Text] [PDF]